• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    With Fermion, start the journey of your innovative API.
    All News #Library
    Biotech

    EU Approves Biocon Biologics` Denosumab Biosimilars

    PR NEWSWIRE

    Novartis Drug Cosentyx Fails Late-Stage Trial for Artery Disease

    REUTERS

    RFK Jr. Eyes Changes to Vaccine Injury Compensation Program

    PRESS RELEASE

    US FDA Approves Regeneron`s Blood Cancer Therapy

    PRESS RELEASE

    WuXi XDC Announces Mechanical Completion of Singapore Site

    INDPHARMAPOST

    Biotech Leaders, Investors urge FDA to Preserve Access

    BIOSPACE

    Kennedy Follows RSV Recommendations of ACIP Members He Fired

    BIOSPACE

    Sage`s Search for Lifeline Ran Into Defiant Biogen CEO

    BIOSPACE

    Oxford BioTherapeutics Advances Third Oncology Drug

    GLOBENEWSWIRE

    BioAtla unveils BA3182 data in refractory adenocarcinoma at ESMO

    GLOBENEWSWIRE

    Taysha Gene Therapies Grants Inducement Under Nasdaq Listing Rule

    GLOBENEWSWIRE

    Opus Genetics announces inducement grants under Nasdaq rule

    GLOBENEWSWIRE

    Luxembourg Law Mandates Issuer Transparency Under Article 13

    GLOBENEWSWIRE

    Biological Safety Testing Services Market Rises with Biologics

    PHARMAWEB

    Biosynth Expands Berlin Site, Adds New Commercial Bioconjugation

    BUSINESSWIRE

    US FDA Grants End of Phase 2 Meeting to OS Therapies

    BUSINESSWIRE

    Precisio Biotix Doses First Patient with ClyO for Joint Infection

    BUSINESSWIRE

    Immunome grants inducement under Nasdaq Listing Rule 5635(c)(4)

    BUSINESSWIRE

    ISS, Glass Lewis Join Back Current SINOVAC Board in Vote

    BUSINESSWIRE

    InnoCare Greenlights Clinical Trial for Novel ADC ICP-B794

    BUSINESSWIRE

    Akeso Launches First Bispecific ADC in Clinical Trials

    PR NEWSWIRE

    MaryJane Rafii joins MOTE Therapeutics to drive global growth

    PR NEWSWIRE

    INOVIO Announces Pricing of $25 Million Public Offering

    PR NEWSWIRE

    Innocan: Promising LPT-CBD Results in Minipigs, Update Shared

    PR NEWSWIRE

    Brii Licenses BRII-693 Rights in Greater China to Joincare Group

    PR NEWSWIRE

    Novogene Adds Fifth NovaSeq X Plus System in Europe

    PR NEWSWIRE

    Zhengye Biotechnology reports Fiscal Year 2024 financial results

    PR NEWSWIRE

    Delhi Hc Seeks Regulator`s Reply on Ozempic, Mounjaro Nod in Pil

    ECONOMICTIMES

    Biokin, having landed BMS deal, posts ph. 3 Bispecific ADC win

    FIERCE BIOTECH

    Sandoz Pumps $440 M Into Another Slovenia Biosimilar Plant

    FIERCE PHARMA

    AstraZeneca Pharma India Approved for Endometrial Cancer

    EXPRESSPHARMA

    Lyme IgM and IgG ImmunoBlots Receive FDA Clearance

    ACCESSWIRE

    Tonix Pharmaceuticals Announces Publication in Journal

    GLOBENEWSWIRE

    Shattuck Labs to Join Leerink Partners Therapeutics Forum

    GLOBENEWSWIRE

    Invivyd Launches SPEAR Study on Long COVID Treatment

    GLOBENEWSWIRE

    BriaCell Adds Phase 3 Sites in Los Angeles and Yale Hospital

    GLOBENEWSWIRE

    Pneumagen Publishes Positive Phase 2 Data for Neumifil

    GLOBENEWSWIRE

    Primo Biotechnology secures funding for 2026 IPO

    GLOBENEWSWIRE

    I-Mab Presents Positive Givastomig Phase 1b Data at ESMO GI 2025

    GLOBENEWSWIRE

    Lixte Biotechnology Holdings Closes $5.0M Private Placement

    GLOBENEWSWIRE

    4DMT Accelerates 4D-150 Phase 3 Develop in Wet AMD, Restructures

    GLOBENEWSWIRE

    Oragenics Completes Approximately $16.5 Million Offering

    GLOBENEWSWIRE

    Xilio Therapeutics Announces Inducement Grants Under Nasdaq Rule

    GLOBENEWSWIRE

    Theratechnologies to be Acquired by CB Biotechnology

    GLOBENEWSWIRE

    Shionogi Offers $600 M for Swiss Biotech`s Antibiotic Program

    FIERCE BIOTECH

    RFK Jr. Enlists Team to Revamp Vaccine Injury Compensation in US

    FIERCE PHARMA

    Argenx Makes $1.5B+ Play for UNP’s Macrocyclic Peptides

    BIOSPACE

    Fresenius Adds Denosumab Biosimilars to U.S. Portfolio

    CONTRACTPHARMA

    Alligator to Present 24-Month OPTIMIZE-1 Data at ESMO GI 2025

    ACCESSWIRE

    UK MHRA Clears First Human Trial of Rincell-1 for Hearing Loss

    GLOBENEWSWIRE

    Alvotech and Advanz Pharma Partner for Biosimilar to Cimzia®

    GLOBENEWSWIRE

    Bio Usawa, Bioeq Partner to Expand Vision Drug Access in Africa

    GLOBENEWSWIRE

    Beacon Exercises Option for AAV204 Gene Therapy Capsid

    GLOBENEWSWIRE

    clonoSEQ® MRD Testing Integrated into OncoEMR®

    GLOBENEWSWIRE

    Aptose Upgraded to Trade on OTCQB Market

    GLOBENEWSWIRE

    Genmab Announces Changes to its Executive Committee

    GLOBENEWSWIRE

    CytoDyn Reports Positive Survival Data in Colorectal Cancer

    GLOBENEWSWIRE

    Celularity Applauds Florida Stem Cell Access Law

    GLOBENEWSWIRE

    Evaxion optimizes Executive Management for AI-Immunology

    GLOBENEWSWIRE

    GRI Bio Completes Phase 2a Enrollment for IPF Candidate

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.